# IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

> **NCT07478315** · NA · NOT_YET_RECRUITING · sponsor: **Charles LeMoyne Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** withdrawal of the premedication

## Key facts

- **NCT ID:** NCT07478315
- **Lead sponsor:** Charles LeMoyne Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478315, "IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07478315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*